Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach
Abstract Background Feline injection-site sarcoma (FISS), an aggressive iatrogenic subcutaneous malignancy, is challenging to manage clinically and little is known about the molecular basis of its pathogenesis. Tumor transcriptome profiling has proved valuable for gaining insights into the molecular...
Main Authors: | Qi Wei, Stephen A. Ramsey, Maureen K. Larson, Noah E. Berlow, Donasian Ochola, Christopher Shiprack, Amita Kashyap, Bernard Séguin, Charles Keller, Christiane V. Löhr |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5501-z |
Similar Items
-
Feline Soft Tissue Sarcomas: A Review of the Classification and Histological Grading, with Comparison to Human and Canine
by: Melanie Dobromylskyj
Published: (2022-10-01) -
Investigating the role of signal transducer and activator of transcription 3 in feline injection site sarcoma
by: Cheng-Hsin Shih, et al.
Published: (2022-07-01) -
Role of nuclear factor-kappa B in feline injection site sarcoma
by: Cheng-Shun Hsueh, et al.
Published: (2019-10-01) -
Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
by: Hiroyuki Komatsu, et al.
Published: (2023-06-01) -
Histotripsy ablation for the treatment of feline injection site sarcomas: a first-in-cat in vivo feasibility study
by: Lauren Ruger, et al.
Published: (2023-12-01)